Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia.

Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia.
复制标题

DOI:
10.1038/ng.587
复制
发表时间:
2010-06
期刊:
影响因子:
30.8
通讯作者:
--
中科院分区:
生物学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

PTPN2(蛋白酪氨酸磷酸酶非受体2型,也称为TC-PTP)是一种细胞质酪氨酸磷酸酶,作为多种酪氨酸激酶和其他信号蛋白的负调节因子。与其在免疫系统调节中的作用一致,PTPN2被确定为自身免疫性疾病的易感性位点。在这项工作中,我们描述了PTPN2在人t细胞急性淋巴细胞白血病(T-ALL)中的局灶性缺失的鉴定。PTPN2缺失在TLX1转录因子癌基因异常表达的t - all中被特异性发现,包括4例也表达NUP214-ABL1酪氨酸激酶的病例。抑制PTPN2表达增加T-ALL细胞的增殖和细胞因子敏感性。此外,PTPN2被鉴定为NUP214-ABL1激酶活性的负调节因子。我们的研究为PTPN2的肿瘤抑制作用提供了遗传和功能证据,并表明PTPN2的表达水平可能调节对治疗的反应。
PTPN2 (protein tyrosine phosphatase non-receptor type 2, also known as TC-PTP) is a cytosolic tyrosine phosphatase that functions as a negative regulator of a variety of tyrosine kinases and other signaling proteins. In agreement with its role in the regulation of the immune system, PTPN2 was identified as a susceptibility locus for autoimmune diseases. In this work, we describe the identification of focal deletions of PTPN2 in human T-cell acute lymphoblastic leukemia (T-ALL). Deletion of PTPN2 was specifically found in T-ALLs with aberrant expression of the TLX1 transcription factor oncogene, including four cases also expressing the NUP214-ABL1 tyrosine kinase. Knockdown of PTPN2 expression increased the proliferation and cytokine sensitivity of T-ALL cells. In addition, PTPN2 was identified as a negative regulator of NUP214-ABL1 kinase activity. Our study provides genetic and functional evidence for a tumor suppressor role of PTPN2, and suggests that expression levels of PTPN2 may modulate response to treatment.
DOI: 10.1128/mcb.01234-06
发表时间: 2007-03-01
影响因子: 5.3
作者:
Lu, Xiaoqing;Chen, Jun;Lossos, Izidore S.
通讯作者: Lossos, Izidore S.
DOI: 10.1084/jem.20042524
发表时间: 2005-06-06
期刊: The Journal of experimental medicine
影响因子: --
作者:
Dik WA;Pike-Overzet K;Weerkamp F;de Ridder D;de Haas EF;Baert MR;van der Spek P;Koster EE;Reinders MJ;van Dongen JJ;Langerak AW;Staal FJ
通讯作者: Staal FJ
DOI: 10.1182/blood-2004-12-4897
发表时间: 2005-06-15
期刊: BLOOD
影响因子: 20.3
作者:
De Keersmaecker, K;Graux, C;Cools, J
通讯作者: Cools, J
DOI: 10.1016/s1535-6108(02)00018-1
发表时间: 2002-02-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Ferrando, AA;Neuberg, DS;Look, AT
通讯作者: Look, AT
DOI: 10.1074/jbc.272.34.21548
发表时间: 1997-08-22
影响因子: 4.8
作者:
Tiganis, T;Flint, AJ;Tonks, NK
通讯作者: Tonks, NK